AI-augmented innovation: Enabling DMTA with digital-physical synergy
Andrew Anderson, Vice President, Innovation and Informatics Strategy at ACD/Labs, looks at how AI is enabling true drug design. Innovators in the pharma and biopharma sectors are actively seeking systems that accelerate the discovery, development, and commercialisation of new products. Of particular interest are systems to support the implementation of… Read More